GrantQuick

Eligibility Matcher

Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.

463 grants for Nonprofits without 501(c)(3) status

Sorted by deadline (soonest first)

Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-DA-27-007

Closes Oct 1, 2026

Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)

HHS-NIH11 · RFA-HD-27-006

Closes Oct 2, 2026

Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-RM-27-014

Closes Oct 2, 2026

Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-RM-27-015

Closes Oct 2, 2026

Protecting and Improving Global Health Security by Engaging Local Partners: Strengthening and Sustaining Public Health Systems in Ghana

HHS-CDC-GHC · CDC-RFA-JG-26-0047

Closes Oct 2, 2026

Strengthening global health security in India to contain public health threats and accelerate outbreak response

HHS-CDC-GHC · CDC-RFA-JG-26-0051

Closes Oct 2, 2026

Expanding Global Health Security through local partnerships in Senegal

HHS-CDC-GHC · CDC-RFA-JG-26-0048

Closes Oct 2, 2026

Strengthening Global Health Security through local partnerships in Sierra Leone

HHS-CDC-GHC · CDC-RFA-JG-26-0050

Closes Oct 2, 2026

Expanding global health security through local partnerships in Ethiopia

HHS-CDC-GHC · CDC-RFA-JG-26-0046

Closes Oct 2, 2026

Improving global health security in Côte d'Ivoire to stop the spread of infectious disease

HHS-CDC-GHC · CDC-RFA-JG-26-0042

Closes Oct 2, 2026

Expanding global health security though local partnerships in Tanzania

HHS-CDC-GHC · CDC-RFA-JG-26-0052

Closes Oct 2, 2026

Expanding global health security through local partnerships in Nigeria

HHS-CDC-GHC · CDC-RFA-JG-26-0043

Closes Oct 2, 2026

Expanding global health security through local partnerships in Indonesia

HHS-CDC-GHC · CDC-RFA-JG-26-0053

Closes Oct 2, 2026

NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)

HHS-NIH11 · PAR-25-445

Closes Oct 3, 2026

Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)

HHS-NIH11 · RFA-DK-26-315

Closes Oct 6, 2026

BJA FY 2026 The Kevin and Avonte Program: Reducing Injury and Death of Missing Individuals with Dementia and Developmental Disabilities

USDOJ-OJP-BJA · O-BJA-2026-172697

Closes Oct 6, 2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

HHS-NIH11 · RFA-DK-27-121

Closes Oct 9, 2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-DK-27-136

Closes Oct 9, 2026

Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-RM-27-011

Closes Oct 9, 2026

Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)

HHS-NIH11 · RFA-MH-27-135

Closes Oct 11, 2026

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

HHS-NIH11 · PAR-23-287

Closes Oct 14, 2026

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

HHS-NIH11 · PAR-25-075

Closes Oct 14, 2026

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

HHS-NIH11 · PAR-23-286

Closes Oct 14, 2026

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

HHS-NIH11 · PAR-25-074

Closes Oct 14, 2026

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

HHS-NIH11 · PAR-24-304

Closes Oct 14, 2026
← PrevPage 5 of 19Next →